High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus–specific T-cell counts
Authors:
- 1 August 2019
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 21 (8) , 886-894
Abstract
No abstract availableKeywords
Funding Information
- Alberta Innovates - Health Solutions
This publication has 20 references indexed in Scilit:
- Immune Cell Subset Counts Associated with Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2014
- The interplay between Epstein–Barr virus and B lymphocytes: implications for infection, immunity, and diseaseImmunologic Research, 2014
- Development and Validation of a Test Dose Strategy for Once-Daily i.v. Busulfan: Importance of Fixed Infusion Rate DosingTransplantation and Cellular Therapy, 2012
- High Epstein–Barr virus-specific T-cell counts are associated with near-zero likelihood of acute myeloid leukemia relapse after hematopoietic cell transplantationLeukemia, 2011
- The Addition of 400 cGY Total Body Irradiation to a Regimen Incorporating Once-Daily Intravenous Busulfan, Fludarabine, and Antithymocyte Globulin Reduces Relapse Without Affecting Nonrelapse Mortality in Acute Myelogenous LeukemiaTransplantation and Cellular Therapy, 2010
- Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortalityBone Marrow Transplantation, 2007
- Successful Immune Reconstitution Decreases Leukemic Relapse and Improves Survival in Recipients of Unrelated Cord Blood TransplantationTransplantation and Cellular Therapy, 2006
- Rapid helper T-cell recovery above 200 × 106/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantationBone Marrow Transplantation, 2006
- Immune reconstitution at 6 months following t-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcomeTransplantation, 2002
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000